HKD 6.09
(-1.62%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.21 Billion CNY | 58.81% |
2022 | 763.49 Million CNY | 20596.45% |
2021 | 3.68 Million CNY | 100.43% |
2020 | -867.79 Million CNY | 0.0% |
2019 | - CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 1.41 Billion CNY | 18.38% |
2023 FY | 1.21 Billion CNY | 58.81% |
2023 Q2 | 1.09 Billion CNY | 43.76% |
2023 Q4 | 1.21 Billion CNY | 10.47% |
2022 Q4 | 763.49 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | 1687.642% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 76.979% |